Back to trial detailsIntake questionnaire
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Applying to Accellacare US Inc · Raleigh, North Carolina
Answer a few short questions to share with the research team.
0 of 4 answered